Bruker Corporation $BRKR Position Increased by Hantz Financial Services Inc.

Hantz Financial Services Inc. boosted its stake in Bruker Corporation (NASDAQ:BRKR) by 774.8% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 13,647 shares of the medical research company’s stock after purchasing an additional 12,087 shares during the period. Hantz Financial Services Inc.’s holdings in Bruker were worth $443,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently added to or reduced their stakes in BRKR. Sector Gamma AS boosted its position in Bruker by 28.0% during the 3rd quarter. Sector Gamma AS now owns 250,909 shares of the medical research company’s stock worth $8,152,000 after acquiring an additional 54,939 shares during the period. State of New Jersey Common Pension Fund D raised its stake in shares of Bruker by 39.0% during the second quarter. State of New Jersey Common Pension Fund D now owns 51,828 shares of the medical research company’s stock valued at $2,135,000 after purchasing an additional 14,547 shares in the last quarter. Buckhead Capital Management LLC lifted its holdings in Bruker by 74.2% in the second quarter. Buckhead Capital Management LLC now owns 59,348 shares of the medical research company’s stock worth $2,445,000 after purchasing an additional 25,288 shares during the period. VELA Investment Management LLC grew its position in Bruker by 80.0% in the 2nd quarter. VELA Investment Management LLC now owns 123,591 shares of the medical research company’s stock valued at $5,092,000 after buying an additional 54,928 shares in the last quarter. Finally, New York State Common Retirement Fund increased its stake in Bruker by 52.5% during the 3rd quarter. New York State Common Retirement Fund now owns 370,797 shares of the medical research company’s stock valued at $12,047,000 after buying an additional 127,698 shares during the period. 79.52% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

BRKR has been the subject of a number of research analyst reports. Rothschild & Co Redburn set a $60.00 price target on shares of Bruker in a research note on Thursday, November 20th. Guggenheim boosted their target price on Bruker from $53.00 to $58.00 and gave the stock a “buy” rating in a report on Monday, January 26th. JPMorgan Chase & Co. upped their target price on Bruker from $50.00 to $55.00 and gave the stock an “overweight” rating in a research report on Monday, December 15th. TD Cowen reiterated a “hold” rating on shares of Bruker in a research report on Wednesday, January 7th. Finally, Bank of America boosted their price objective on Bruker from $43.00 to $60.00 and gave the stock a “buy” rating in a research note on Monday, December 15th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have given a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $53.23.

Bruker Price Performance

Shares of NASDAQ:BRKR opened at $41.93 on Friday. The company has a market capitalization of $6.37 billion, a PE ratio of -262.06, a price-to-earnings-growth ratio of 5.51 and a beta of 1.19. The company has a debt-to-equity ratio of 0.81, a quick ratio of 0.91 and a current ratio of 1.85. The stock has a fifty day moving average of $47.71 and a 200-day moving average of $40.54. Bruker Corporation has a one year low of $28.53 and a one year high of $56.48.

Insider Activity at Bruker

In related news, VP Mark Munch sold 2,000 shares of the stock in a transaction on Thursday, January 15th. The stock was sold at an average price of $49.20, for a total value of $98,400.00. Following the completion of the transaction, the vice president owned 128,443 shares in the company, valued at $6,319,395.60. This trade represents a 1.53% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 27.30% of the stock is currently owned by corporate insiders.

Bruker Profile

Bruker Corporation, founded in 1960 by physicist Günther Laukien and headquartered in Billerica, Massachusetts, is a leading developer and manufacturer of high-performance scientific instruments and analytical solutions. The company designs systems that enable molecular and materials research across academic, governmental, and industrial laboratories.

Bruker’s product portfolio encompasses nuclear magnetic resonance (NMR) spectrometers for molecular structure and dynamics studies, mass spectrometry platforms for proteomics and metabolomics, X-ray diffraction and scattering instruments for crystallography and materials characterization, atomic force and scanning probe microscopes for nanoscale surface analysis, as well as preclinical imaging systems such as micro-CT and MRI scanners.

In addition to hardware, Bruker provides software suites, applications support, training services, and long-term maintenance agreements to ensure optimal instrument performance.